Press Releases
The official home of Magnus Medical press releases. View our latest announcements and corporate updates regarding the path toward more effective depression care.
Press Releases
Magnus Medical Moves to Protect Intellectual Property Behind Breakthrough SAINT Accelerated Depression Therapy
Magnus Medical Inc., exclusive licensee of a collection of pioneering accelerated neuromodulation patents, today reaffirmed…
Press Releases
Magnus Medical Announces First Patient Enrolled at University of Massachusetts in Pivotal DoD-Funded Multisite Study of SAINT for Postpartum Depression
BURLINGAME, Calif., Feb. 5, 2026 — Magnus Medical, Inc., a pioneering therapeutic neuromodulation company advancing…
Press Releases
Magnus Medical Announces Uninterrupted 2026 Payment Stability for SAINT Neuromodulation in CMS OPPS Final Rule
Final Rule maintains SAINT® Depression Therapy reimbursement framework, ensuring payment continuity for hospitals and hospital-based…
Press Releases
Magnus Medical Announces CMS Approval of New Payment Rate for SAINT Treatment in 2025 Hospital Outpatient Rule
Press Releases
Magnus Medical Highlights New Clinical Data on Groundbreaking SAINT Therapy at 2024 NYC Neuromodulation Conference
Press Releases
Magnus Medical Announces Commercial Launch of Groundbreaking SAINT Neuromodulation System
Press Releases
Magnus Medical Announces American Medical Association Issues New CPT Category III Codes for Targeted, Accelerated Intermittent Theta-Burst Stimulation
Press Releases
Magnus Medical Announces First Participants Treated in Study Using SAINT Neuromodulation System for Major Depression
Press Releases
Magnus Medical Shares New Study Results That Find Treatment With SAINT for Severe Depression Changes Abnormal Brain Signals
Find SAINT® near you
The path to feeling better is here. Find a Verified SAINT Provider near you.
